Oct 7, 2026 04:35AM
Sep 25, 2026 06:06AM
Jul 30, 2026 08:05AM
Jun 8, 2026 04:05PM
May 12, 2026 05:06PM
Apr 15, 2026 04:05PM
Apr 7, 2026 08:08AM Savara receives UK regulatory acceptance for rare lung disease drug
Mar 31, 2026 04:27AM
Mar 30, 2026 03:41PM
Mar 16, 2026 11:22AM
Mar 13, 2026 08:06AM
Mar 6, 2026 04:05PM
Feb 23, 2026 04:58AM
Feb 20, 2026 04:15PM FDA files Savara's MOLBREEVI application for rare lung disease
Jan 27, 2026 08:06AM
Dec 23, 2025 06:46AM
Dec 23, 2025 06:42AM
Dec 22, 2025 08:31AM
Dec 11, 2025 08:05AM
Dec 8, 2025 07:32AM
Dec 2, 2025 08:06AM Savara and PARI receive European patent for drug-device combination
Nov 13, 2025 06:36AM
Nov 13, 2025 04:15AM
Oct 29, 2025 04:01PM
Oct 23, 2025 04:25AM
Sep 9, 2025 06:56AM
Sep 4, 2025 06:41AM
Sep 2, 2025 09:01AM Savara finds 50% more autoimmune PAP patients in US claims data study
Aug 21, 2025 04:11AM
Aug 15, 2025 08:58AM
Aug 15, 2025 08:14AM
Aug 13, 2025 07:02PM
Jun 5, 2025 11:58AM
Jun 2, 2025 08:58AM
May 29, 2025 06:07AM H.C. Wainwright Downgrades Savara (SVRA) to Neutral
May 28, 2025 07:09AM
May 28, 2025 07:07AM
May 27, 2025 08:06AM
May 13, 2025 04:19PM
Apr 23, 2025 04:28AM
Apr 11, 2025 09:44AM
Apr 7, 2025 04:05PM Savara (SVRA) Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution
Mar 28, 2025 06:42AM
Mar 27, 2025 04:55AM
Mar 26, 2025 04:46PM
Mar 26, 2025 04:05PM
Mar 6, 2025 08:07AM
Jan 30, 2025 08:39AM
Dec 18, 2024 04:07PM Savara (SVRA) Initiates Rolling Submission of BLA to FDA for MOLBREEVI for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis
Nov 13, 2024 06:54AM

479,656 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All